In vitro and in vivo studies have demonstrated the role of ADAM9 in the progression of pancreatic cancer by directing such processes such as angiogenesis, cell migration, matrix adhesion extracellular or tumor growth independent of anchors. Here, ADAM9 is linked to neoplasm.